Sinclair Pharma

Sinclair Pharma is an international specialty pharmaceutical company centred on Dermatology, in particular Aesthetics, Wound care, and Skin care. The group has a direct sales and marketing presence in the top five European markets and a rapidly growing International division concentrated on the Emerging Markets through long term multi-product, multi-country, sales, marketing and distribution deals with key strategic partners. Sinclair Pharma plc is listed on the London Stock Exchange AIM market
Type
Public
HQ
London, GB
Founded
1971
Size (employees)
182 (est)
Sinclair Pharma was founded in 1971 and is headquartered in London, GB

Sinclair Pharma Office Locations

Sinclair Pharma has offices in London, Frankfurt am Main, Paris, San Fernando de Henares and in 1 other locations
London, GB (HQ)
Whitfield Court 26-28 Whitfield St
Cheshire West and Chester, GB
Office Village
San Fernando de Henares, ES
Parque Empresarial de San Fernando. Ed Dublin planta 2
Paris, FR
46 Rue de la Bienfaisance
Frankfurt am Main, DE
1 Westhafenpl.

Sinclair Pharma Metrics

Sinclair Pharma Financial Metrics

Revenue (2015)

£75.9 m

Revenue growth (2014-15), %

19%

Gross profit

£47.8 m

Gross profit margin (2015), %

63%

Market capitalization (22-Mar-2017)

£167.3 m

Closing share price (22-Mar-2017)

£0.3
Sinclair Pharma's current market capitalization is £167.3 m.
Sinclair Pharma's revenue was reported to be £75.9 m in FY, 2015 which is a 19.4% increase from the previous period.
FY, 2013FY, 2014FY, 2015

Revenue

£55.4 m£63.6 m£75.9 m

Revenue growth, %

15%19%

Cost of goods sold

£21.7 m£27.8 m£28.1 m

Gross profit

£33.6 m£35.8 m£47.8 m

Gross profit Margin, %

61%56%63%

Operating expense total

£49 m£37.5 m£43.2 m

Sinclair Pharma Operating Metrics

FY, 2016

Training Provided, no. of people

300

    Sinclair Pharma Market Value History

    Sinclair Pharma Company Life

    You may also be interested in